A Double-Blind, Placebo-Controlled, Randomized Trial to Evaluate the Safety, Tolerability and Efficacy of CONCERTA (Methylphenidate Hydrochloride) Augmentation of SSRI/SNRI Monotherapy in Adult Patients With Major Depressive Disorder

Trial Profile

A Double-Blind, Placebo-Controlled, Randomized Trial to Evaluate the Safety, Tolerability and Efficacy of CONCERTA (Methylphenidate Hydrochloride) Augmentation of SSRI/SNRI Monotherapy in Adult Patients With Major Depressive Disorder

Completed
Phase of Trial: Phase III

Latest Information Update: 04 May 2010

At a glance

  • Drugs Methylphenidate (Primary)
  • Indications Depression; Major depressive disorder
  • Focus Therapeutic Use
  • Sponsors Janssen Inc
  • Most Recent Events

    • 19 Oct 2007 Status changed fro min progress to completed.
    • 18 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top